tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Disc Medicine’s APOLLO Study: A Potential Game-Changer for EPP and XLP Treatment
PremiumCompany AnnouncementsDisc Medicine’s APOLLO Study: A Potential Game-Changer for EPP and XLP Treatment
12d ago
Disc Medicine’s New Study on DISC-3405: A Potential Breakthrough for Sickle Cell Disease
Premium
Company Announcements
Disc Medicine’s New Study on DISC-3405: A Potential Breakthrough for Sickle Cell Disease
12d ago
Disc Medicine’s Promising Phase 2 Study on DISC-3405 for Polycythemia Vera
Premium
Company Announcements
Disc Medicine’s Promising Phase 2 Study on DISC-3405 for Polycythemia Vera
12d ago
Disc Medicine $250M Spot Secondary priced at $84.00
PremiumThe FlyDisc Medicine $250M Spot Secondary priced at $84.00
18d ago
Disc Medicine’s Strategic Positioning and Growth Potential Highlighted by Analyst’s Buy Rating
Premium
Ratings
Disc Medicine’s Strategic Positioning and Growth Potential Highlighted by Analyst’s Buy Rating
18d ago
Disc Medicine Updates Hematology Portfolio and Strategic Priorities
Premium
Company Announcements
Disc Medicine Updates Hematology Portfolio and Strategic Priorities
19d ago
Disc Medicine rises 25.5%
PremiumThe FlyDisc Medicine rises 25.5%
22d ago
Disc Medicine price target raised to $153 from $132 at Cantor Fitzgerald
Premium
The Fly
Disc Medicine price target raised to $153 from $132 at Cantor Fitzgerald
22d ago
Disc Medicine Receives FDA Priority Voucher for Bitopertin
Premium
Company Announcements
Disc Medicine Receives FDA Priority Voucher for Bitopertin
22d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100